News Tag: 2023 newsletters

Not Leaving Veterans Behind

Read More

Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from Small Cell Lung Cancer (NRG-CC009)

Read More

Should SRS be Delivered Before or After Surgery for Patients with Brain Metastases? (NRG-BN012)

Read More

FORTE at #NRG2023!

Read More

Comparing Selumetinib and Olaparib to Selumetinib Alone for Ovarian and Endometrial Cancers with RAS Pathway Mutations (EAY191-N4, A ComboMATCH Treatment Trial)

Read More

Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone-Receptor Positive Metastatic Breast Cancer (EAY191-N2, A ComboMATCH Treatment Trial)

Read More

WVOCA Donates Additional Funds to the NRG Oncology Health Equity Fellowship Program

Read More

PI Perspective: The Journey of NRG-GY018

Read More

NRG Oncology and RTOG Foundation Integrated Efforts in the Head and Neck Cancer Committee

Read More